La cicatrización queloide
DOI:
https://doi.org/10.51481/amc.v50i2.362Palabras clave:
cicatriz, queloide, colágenaResumen
La cicatriz es el estado final y definitivo de la reparación que el organismo efectúa en una herida accidental, quirúrgica o producida por alguna afección. La cicatrización queloide es un desorden en la estructura normal de la colágena, que conduce a un crecimiento anormal y desproporcionado de las fases normales de la cicatrización, siendo esta un efecto indeseable para todo cirujano. Fue descrita por primera vez en 1.700 a. de J.C. en el papiro de Edwin Smith; sin embargo, no fue hasta en 1802 cuando Alibert usó el término queloide (cheloid=tenaza de cangrejo), por la forma de la lesión. En este artículo se realiza una actualización de esta enfermedad cicatrizal dermoepidérmica, neoplásica.
Descargas
Citas
Breasted JH. The Edwin Smith surgical papyrus: hieroglyphic translation and comentary. Chicago. University of Chicago Press. 1930; 403.
Murray JC. Scars and keloids. Dermatol Clin. 1993; 11:697.
Cosman B, Crickelair GF, Ju MC, Gualin JC, Lattes R. The surgical treatment of keolidal scars. Plast Reconst Surg. 1961; 27:335-358.
Urioste SS, Arndt KA, Dover JS. Keloidal scars and hypertrophic scars: review and treatment strategies. Semin Cutan Med Surg. 1999; 18:159-171.
Marneros AG. Clinical genetics of familial keloids. Arch Dermatol. 2001; 137:1429-34.
Norman B, Bieley HC. Adjunct therapies to surgical management of Keloids. Dermatol Surg. 1996; 2:126.
Datubo-Brown DD. Keloids: a review of the literature. Br J Plast Surg. 1990; 43: 70-77.
Niessen FB, Spauwen PH, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloidal scars: a review. Plast Reconstr Surg. 1999; 105: 1435-1458.
Mathangi-Ramarkrishnan K, Pothan-Thomas K, Cheyyur R. Study of 1,000 patients with keloidal scars in South India. Plast Reconst Surg. 1974; 53: 276-280.
Norris JE. Superficial X-Ray Therapy in Keloid Management: A retrospective study of 24 cases and literatura review. Plast Reconstr Surg. 1995; 95: 1051.
Oluwasanmi JO. Keloids in the African. Clin Plast Surg. 1974; 1: 179.
Rockwell WB, Cohen IK, Ehrlich HP. Keloids and hypertrophic scars: A comprenhensive review. Plast Reconst Surg. 1989; 84:827.
Coiffman F. El colágeno inyectable en cirugía plástica. Coiffman F. Cirugía plástica, reconstructiva y estética. Segunda edición. Barcelona: Masson. 1994; 2425.
Pollack SV, Gosten JB. The surgical treatment of keloidal scars. J Dermatol Surg Oncol. 1982; 8: 1045-1049.
Ackerman AB. Differential diagnosis in dermatolology. Philadelphia & Febiger. 1982.
Schwartz SI, Shires GT, Spencer FC, Fischer JE, Gallowai AC, Daly JM, eds. Principios de Cirugía. 7ª ed. México: McGraw Hill Interamericana; 2000.
Lawrence WT. In search of the optimal treatment of keloids: Report of a series and review of the literature. Ann Plast Surg 1991; 27:164.
Niessen FB, Sapuwen PH, Shalkwiijk KJ, et al. On nature of hypertrophic scars of 24 cases and literature review. Plast Reconst Surg 1991; 87:50.
Coiffman F. Cirugía plástica, reconstructiva y estética. 2ª ed. Barcelona: Mason-Salvat; 1994.
Errol J. Keloids. Conn´s current therapy. Rakel. 54th ed. 799-801.
Tepmonkol P. Radiation therapy in the treatment of keloids. J Med Asscoc Thai. 1978; 61:20-5.
Doombos JF. The role of kilovoltage irradiation in the treatment of keloids. Int J Radiat Oncol Biol Physiol. 1990; 18:833-9.
Botwood N, Lewanski C, Lowdell C. The risk of treating keloids with radiotherapy. Br J Radiol. 1999; 72: 1222-44.
Bilbey JH, Muller NL, Miller RR, Nelemus B. Localized fibrous mesothelioma of pleura following external ionizing radiation therapy. Chest. 1988; 94:1291-2.
Luo S, Benathan M, Raffoul N, Panizzan RG and Egloff DV. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconst Surg. 2001; 107:87
Asawananda P, Khoo LS, Fitzpatrick TB, Taylor CR. UV-A1 for keloid. Arch Dermatol. 1999; 135:348-9.
Hannuksela-Svahn A, Grandal OJ, Thorstensen T, Christensen OB. UVA 1 for treatment of keloids. Acta Deramtol Venereal. 1999; 79:490.
Abergel RP, Dwyer RM, Meeker CA, Uitto J, Lask G, Nelly AP. Laser treatment of keloids: A clinical trial and an in vitro study with Nd: YAG laser. Lasers Surg Med. 1984; 4:291-295.
Apfelberg DB, Maser MR, White DN, Lash H. Failure of carbon dioxide laser excition of keloids. Laser Surg Med. 1989; 9:382-388.
Apfelberg DB, Maser MR, Dds HL, White D, Weston J. Preliminary results of argon and carbon dioxide laser treatment of keloid scars. Laser Surg Med. 1984; 4:283-290.
Bailin P. Use of the CO2 laser for non-PWS cutaneous lesions. In: Arndt KA, Noe JM, Rosen S, editors. Cutaneous laser therapy: Principles and Methods. New York: John Wiley; 1983. p. 187-200.
Henderson DL, Cromwell TA, Mes LG. Argon and carbon dioxide laser treatment of hypertrophic and keloid scars. Laser Surg Med. 1984;3:271-277.
Hulsbergen-Henning JP, Roskam Y. Treatment of keloids and hypertrophic scars with and argon laser. Lasers Surg Med. 1986;6:7275.
Norris JE. The effect of carbon dioxide laser surgery on the recurrence of keloids. Plast Reconstr Surg. 1991;87:44-49.
Sherman R, Rosenfeld H. Experience with the Nd:YAG laser in the treatment of keloid scars. Ann Plast Surg. 1988; 21:231-235.
Stern JC, Lucente FE. Carbon dioxide laser excision of earlobe keloids. A prospective study and critical análisis of existing data. Arch Otolaryngol Head Neck Surg. 1989; 115:1107-1111.
Alster TS. Improvement of erythematous and hypertrophic scars by the 585nm pulsed dye laser. Am Plast Surg. 1994; 32:186-190.
Alster TS, Kurban AK, Grove GL, Grove MJ, Tian Tan O. Alteration of argon laser-induced scars by the pulsed dye laser. Lasers Surg Med. 1993; 13:368-373.
Alster TS, Lewis AB, Rosenbach A. Laser scar revision: comparison of CO2 laser vaporization with and without simultaneous pulsed dye laser. Dermatol Surg. 1998; 24:1299-1302.
Alster TS, McMeekin TO. Improvement of facial acne scars by the 585nm flashlamp-pumped dye laser. J Am Acad Dermatol. 1996; 35:79-81.
Alster TS, Nanni CA. Pulsed dye laser treatment of hypertrophic burn scars. Plast Reconstr Surg. 1998; 102:2190-2195.
Alster TS, Williams CM. Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed dye laser. Lancet. 1995; 345:11981200.
Dierickx C, Goldman MP, Fitzpatrick RE. Laser treatment of erythematous/hypertrophic and pigmented scars in 26 patients. Plast Reconst Surg. 1995; 95:84-90.
Aderson RR, Margolis RJ, Watenabe S, Flotte T, Hruza GJ and Dover JS. Selective photo thermolysis of cutaneous pigmentation by Qswitched Nd:YAG laser pulses at 1064, 532 and 355nm. J Invest Dermatol. 1989; 93:28.
Layton AM, Yip J and Cunliffe WJ. A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne Keloids. Br J Dermatol. 1994; 130:498
Har-Shai Y, Amar M and Sabo E. Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids. Plast Reconst Surg. 2003; 111:1841.
Pierce HF. Cryosurgery for hypertrophic scars and keloids. J Natl Med Assoc. 1974; 66:174-5.
Lortat-Jacob FJ. Traitement des cheloides par la cryotherapy. Bull Soc Franc Dermatol Et Slip. 1931; 38:979-81.
Rusciani L, Rossi G, Bono R. Use of cryotherapy in the treatment of keloids. J Dermatol Surg Oncol. 1993; 19:529-34.
Zouboulis CC, Blume U, Buttner P, Orfanos CE. Outcomes of cryosurgery in keloids and hypertrophic scars. A prospective consecutive trial of case series. Arch Dermatol. 1993; 129:1146-51.
Shepherd JP, Dawber RP. The response of keloid scars to cryosurgery. Plast Reconst Surg. 1982; 70:677-81.
Sproat JE, Dalcin A, Weitaver N and Roberts RS. Hypertrophic eternal scars: Silicone gel sheet versus kenalog injection treatment. Plast Reconst Surg. 1992; 90:988.
Gold MH. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Am Acad Dermatol. 1994; 30:506.
Quinn KG, Evans JH, Courtney JM, Gaylor JDS, Reid WH. Nonpressure treatment of hypertrophic scars. Burns 1985;12:102–8.
Quinn KG. Silicone gel in scar treatment. Burns 1987;13:S33–S40.
Davey RB. The use of silicone gel and Silastic foam in burn scar management—how does it work? Presented at the 7th Congress of the International Society for Burn Injuries, Melbourne, Australia, February 1986.
Harrop AR, Grahary A, Scout PG, Forsyth N, Uji-Friendhand A and Tredget EE. Regulation of collagen síntesis and mRNA expresión in normal and hypertrophic scar fibroblasts in vitro by interferon-gamma. J Surg Res. 1995; 58:471.
Tredget EE, Nedelec B, Scout PG and Garrí A. Hypertrophic scars, keloids and contracturas. The cellular and molecular basis for therapy. Surg Clin North Am. 1997; 77:701.
Berman, B., and Duncan, M. R. Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro. J. Am. Acad. Dermatol. 21: 694, 1989.
Espinassouze F, Heid E and Grosshans E. Treatment of keloid by intralesional injections of interferon alfa-2B (in French). Ann Dermatol Venereol. 1993; 120:629.
al Khawajah MM. Failure of interferon-alpha 2b in the treatment of nature keloids. Int J Dermatol. 1996; 35:515.
Conejo-Mir JS, Corbi R. Carbon dioxide laser ablation associated with interferon alfa-2b injections reduces the recurrence of keloids. J Am Acad Dermatol. 1998; 39:1039-40.
Pfenninger, Procedures for Primary Care Physicians. 1est edition. Mosby-Year Book. 1994.
Fitzpatrick R. Intralesional 5-FU in the treatment of hypertrophic scars and keloids: Clinical Experience. Dermatol Surg. 1999; 25:22432.
Darzi MA, Chawdri NA, Kaul SK, Khan M. Evaluation of various methods of treating keloids and hypertrophic scars: a 10 years followup study. Br J Plast Surg. 1992; 45:374-9.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2008 Acta Médica Costarricense
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
